May 16, 2000Open Access

Lack of Benefit for Intravenous Thrombolysis in Patients With Myocardial Infarction Who Are Older Than 75 Years

Key Points

Key points are not available for this paper at this time.

Abstract

In nationwide clinical practice, thrombolytic therapy for patients >75 years old is unlikely to confer survival benefit and may have a significant survival disadvantage. Reperfusion research that is focused on elderly patients is urgently needed.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

David R. Thiemann

Josef Coresh

Steven P. Schulman

Journals

Circulation

Actions

Institutions

Johns Hopkins University

Arkansas Foundation for Medical Care

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Lack of Benefit for Intravenous Thrombolysis in Patients With Myocardial Infarction Who Are Older Than 75 Years

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study